Circulating tumor cell-derived organoids: current challenges and promises in medical research and precision medicine. Praharaj PP, Bhutia SK, Nagrath S, Bitting RL, Deep G.. Biochim Biophys Acta. 2018;1869(2):117-127.
Silibinin treatment inhibits the growth of hedgehog inhibitor resistant basal cell carcinoma cells via targeting EGFR-MAPK-Akt and hedgehog signaling. Dheeraj A, Rigby CM, O'Bryant CL, Agarwal C, Singh RP, Deep G, Agarwal R.. Photochem Photobiol. 2017;93(4):999-1007.
Silibinin inhibits hypoxia-induced HIF-1alpha-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: in vitro evidence and in vivo functional imaging and metabolomics. Deep G, Kumar R, Nambiar DK, Jain AK, Ramteke AM, Serkova NJ, Agarwal C, Agarwal R.. Mol Carcinog. 2017;56(3):833-848.
Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer. Panigrahi GK, Deep G.. Front Biosci (Landmark Ed). 2017;22():1682-1696.
Aberrant lipid metabolism promotes prostate cancer: role in cell survival under hypoxia and extracellular vesicles biogenesis. Deep G, Schlaepfer IR.. Int J Mol Sci. 2016;17(7):E1061.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.